These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs. Murgo AJ. Semin Oncol; 2005 Oct; 32(5):458-64. PubMed ID: 16210086 [Abstract] [Full Text] [Related]
46. New frontiers in cell-based immunotherapy of cancer. D'Elios MM, Del Prete G, Amedei A. Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938 [Abstract] [Full Text] [Related]
51. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM. Cancer Res; 2007 Feb 01; 67(3):1344-51. PubMed ID: 17283172 [Abstract] [Full Text] [Related]
54. Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions. Chicaybam L, Sodré AL, Bonamino M. Int Rev Immunol; 2011 Feb 01; 30(5-6):294-311. PubMed ID: 22053970 [Abstract] [Full Text] [Related]